Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Clearfield, Inc.CLFD · Entity 5688 | Director | February 27, 2026 | March 02, 2026 |
| PENTAIR plcPNR · Entity 3537 | SVP & Chief Accounting Officer | May 31, 2019 | June 04, 2019 |
| STANDEX INTERNATIONAL CORP/DE/SXI · Entity 1314 | Vice President/CFO/Treasurer | August 24, 2026 | August 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Clearfield, Inc.
Report date February 27, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,317 |
Reported balance
After 2026-02-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-27 · Grant · Acquired 2,544 · Balance 5,317 F1: Restrictions on Restricted Stock lapse the first business day prior to the 2027 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Restrictions on Restricted Stock lapse the first business day prior to the 2027 Annual Meeting of Shareholders.
PENTAIR plc
Report date May 31, 2019 · Filed June 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 1,593 |
Reported balance
After 2019-05-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-05-31 · Tax withholding · Disposed 546 · Balance 1,593 F1: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F2: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. |
| Common Shares - Restricted Stock UnitsSEC Table I · non-derivative | Direct | 5,908.155 |
Reported balance
Holding disclosure · report date 2019-05-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,908.155 F2: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. |
| Common SharesSEC Table I · non-derivative | IndirectBy ESOP | 228.535 |
Reported balance
Holding disclosure · report date 2019-05-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 228.535 F3: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). |
Filing footnotes · ownership attribution and instrument terms
F1: Shares surrendered to pay taxes applicable to vesting of restricted stock units.
F2: End-of-period holdings reflect the vesting of restricted stock units that were previously reported.
F3: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).
STANDEX INTERNATIONAL CORP/DE/
Report date August 24, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,486 |
Reported balance
After 2026-08-24 transaction · row 1
1 source rowRow 1 · 2026-08-24 · Sale · Disposed 2,300 · Balance 7,486 F1: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $300.49 to $308.885, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $300.49 to $308.885, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2024 Filed Apr 3, 2024 18:15 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | GrantCommon Stock | 8,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012129 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,736 F1 · kind: Grant of restricted stock pursuant to the 2018 Omnibus Incentive Plan of the Company which vests 50% on the first anniversary of the date of award and 50% on the second anniversary of the date of award, and subject to certain repayment obligations in the event that the reporting person were to voluntarily terminate employment prior to April 1, 2027. F1 · price: Grant of restricted stock pursuant to the 2018 Omnibus Incentive Plan of the Company which vests 50% on the first anniversary of the date of award and 50% on the second anniversary of the date of award, and subject to certain repayment obligations in the event that the reporting person were to voluntarily terminate employment prior to April 1, 2027. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 22:05 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 28 | $154.41 | $4,323.48 |
DisclosureSEC source: 0001127602-24-004507 · form4.xml · nonDerivative · entry 2 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,071 Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 22:05 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 2,400 | $154.31 | $370,344.00 |
DisclosureSEC source: 0001127602-24-004507 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,099 Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 16:16 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 2,000 | $134.13 | $268,260.00 |
DisclosureSEC source: 0001127602-23-027325 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,499 Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 21:55 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 3,100 | $149.51 | $463,471.70 |
DisclosureSEC source: 0001127602-23-023950 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,499 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $148.31 to $151.41, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Exercise / conversionPhantom Stock Units · Derivative | 7,012 | $0.00 Strike: $58.81 | $0.00 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · derivative · entry 8 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,012 shares Expires 2023-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of Phantom Stock pursuant to the Company's 2018 Omnibus Incentive Plan. Actual achievement, which could have ranged from 0% to 250% of the award, was 232%. Thus, the transaction reflected herein reflects the conversion of the original number of units granted and the awarding of the additional amount. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Exercise / conversionPhantom Stock Units · Derivative | 865 | $0.00 Strike: $43.16 | $0.00 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · derivative · entry 7 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 865 shares Expires 2023-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of Phantom Stock pursuant to Company's Management Stock Purchase Plan. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Tax withholdingCommon Stock | 736 | $152.60 | $112,313.60 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · nonDerivative · entry 6 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,599 F4 · kind: Shares sold to pay taxes on vesting of previously issued restricted stock. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Tax withholdingCommon Stock | 6,413 | $152.60 | $978,623.80 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · nonDerivative · entry 5 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,335 F2 · kind: Shares sold to pay taxes on the reported vesting of Phantom Stock. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Exercise / conversionCommon Stock | 9,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · nonDerivative · entry 4 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of Phantom Stock pursuant to the Company's 2018 Omnibus Incentive Plan. Actual achievement, which could have ranged from 0% to 250% of the award, was 232%. Thus, the transaction reflected herein reflects the conversion of the original number of units granted and the awarding of the additional amount. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Exercise / conversionCommon Stock | 7,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · nonDerivative · entry 3 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of Phantom Stock pursuant to the Company's 2018 Omnibus Incentive Plan. Actual achievement, which could have ranged from 0% to 250% of the award, was 232%. Thus, the transaction reflected herein reflects the conversion of the original number of units granted and the awarding of the additional amount. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Tax withholdingCommon Stock | 341 | $152.60 | $52,036.60 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · nonDerivative · entry 2 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,453 F2 · kind: Shares sold to pay taxes on the reported vesting of Phantom Stock. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:52 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Exercise / conversionCommon Stock | 865 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-023948 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of Phantom Stock pursuant to Company's Management Stock Purchase Plan. Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 17:09 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 1,355 | $157.21 | $213,026.05 |
DisclosureSEC source: 0001127602-23-023221 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,929 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $155.88 to $161.31, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:29 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | GrantPhantom Stock Units · Derivative | 602 | $106.10 | $63,873.71 |
DisclosureSEC source: 0001127602-23-023209 · form4.xml · derivative · entry 4 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 602 Underlying: Common Stock · 602 shares Expires 2026-08-23 F4 · derivative.exercise_price: Contingent Purchase of Phantom Stock of the Company pursuant to the Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan vesting three years after the date of purchase in the form of Common Stock. F4 · kind: Contingent Purchase of Phantom Stock of the Company pursuant to the Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan vesting three years after the date of purchase in the form of Common Stock. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:29 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | GrantPhantom Stock Units · Derivative | 2,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-023209 · form4.xml · derivative · entry 3 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,491 Underlying: Common Stock · 2,491 shares Expires 2026-08-23 F3 · derivative.exercise_price: Award of Performance Share Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares cliff vest at the end of a three year performance period with the ultimate number of shares ranging from 0 to 250% of the award based on achievement against Company performance metrics of the three year period. F3 · kind: Award of Performance Share Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares cliff vest at the end of a three year performance period with the ultimate number of shares ranging from 0 to 250% of the award based on achievement against Company performance metrics of the three year period. F3 · price: Award of Performance Share Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares cliff vest at the end of a three year performance period with the ultimate number of shares ranging from 0 to 250% of the award based on achievement against Company performance metrics of the three year period. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:29 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | GrantCommon Stock | 2,491 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-023209 · form4.xml · nonDerivative · entry 2 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,284 F2 · kind: Grant of restricted stock pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third per year on each anniversary of the date of award. F2 · price: Grant of restricted stock pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third per year on each anniversary of the date of award. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:29 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | Tax withholdingCommon Stock | 927 | $158.99 | $147,383.73 |
DisclosureSEC source: 0001127602-23-023209 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,793 F1 · kind: Shares sold to pay taxes on vesting of previously issued restricted stock. Read SEC document |
| May 22, 2023 Filed May 23, 2023 14:45 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 755 | $140.45 | $106,039.75 |
DisclosureSEC source: 0001127602-23-016556 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,720 Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:41 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 800 | $119.00 | $95,200.00 |
DisclosureSEC source: 0001127602-23-009301 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,475 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 20:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 1,000 | $119.32 | $119,322.00 |
DisclosureSEC source: 0001127602-23-003074 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,275 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $119.05 to $120.34, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 35 | $109.70 | $3,839.50 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 13 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,275 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 100 | $109.57 | $10,957.00 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 12 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,310 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 40 | $109.56 | $4,382.20 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 11 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,410 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 60 | $109.53 | $6,571.80 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 10 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,450 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 100 | $109.45 | $10,945.00 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 9 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,510 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 64 | $109.41 | $7,002.24 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 8 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,610 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 100 | $109.40 | $10,940.00 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 7 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,674 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 100 | $109.38 | $10,937.50 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 6 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,774 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 36 | $109.36 | $3,936.96 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 5 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,874 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 3 | $109.34 | $328.02 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 4 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,910 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 62 | $109.24 | $6,772.88 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 3 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,913 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 52 | $109.15 | $5,675.80 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 2 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,975 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:21 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 94 | $109.00 | $10,246.00 |
DisclosureSEC source: 0001127602-23-001451 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,027 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 12, 2023 Filed Jan 17, 2023 17:19 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $109.22 | $5,461.00 |
DisclosureSEC source: 0001127602-23-001448 · form4.xml · nonDerivative · entry 4 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,121 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 12, 2023 Filed Jan 17, 2023 17:19 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $109.10 | $5,455.00 |
DisclosureSEC source: 0001127602-23-001448 · form4.xml · nonDerivative · entry 3 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,171 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 12, 2023 Filed Jan 17, 2023 17:19 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 4 | $109.03 | $436.12 |
DisclosureSEC source: 0001127602-23-001448 · form4.xml · nonDerivative · entry 2 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,221 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 12, 2023 Filed Jan 17, 2023 17:19 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $109.00 | $5,450.00 |
DisclosureSEC source: 0001127602-23-001448 · form4.xml · nonDerivative · entry 1 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,225 F1 · timeliness: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $103.11 | $5,155.50 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 15 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,275 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 2 | $102.83 | $205.66 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 14 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,325 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 4 | $102.60 | $410.40 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 13 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,327 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 69 | $102.49 | $7,071.81 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 12 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,331 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 4 | $102.34 | $409.34 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 11 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,400 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $102.27 | $5,113.50 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 10 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,404 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $102.08 | $5,104.00 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 9 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,454 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 8 | $101.99 | $815.92 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 8 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,504 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $101.92 | $5,096.00 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 7 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,512 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 100 | $101.90 | $10,190.00 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 6 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,562 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 50 | $101.88 | $5,094.00 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 5 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,662 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 15:50 UTC | STANDEX INTERNATIONAL CORP/DE/ SXI · Entity 1314 | SaleCommon Stock | 100 | $101.84 | $10,184.00 |
DisclosureSEC source: 0001127602-23-000272 · form4.xml · nonDerivative · entry 4 Sarcevic Ademir · CIK 0001738830 · Vice President/CFO/Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,712 F1 · kind: Sale of stock pursuant to an existing 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.